Ivabradine - A new therapeutic option for cardiogenic shock?;Ivabradin - eine neue therapieoption bei kardiogenem schock?

Herz

Volumn 34, Issue 3, 2009, Pages 224-229

  Post, Felix ^a   Münzel, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Cardiogenic shock; Heart failure; If channel; Ivabradine; Myocardial infarction

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; DOPAMINE; IVABRADINE; LEVOSIMENDAN; METOPROLOL; PLACEBO;

ARTICLE; CARDIOGENIC SHOCK; CLINICAL TRIAL; DRUG MECHANISM; ENERGY CONSERVATION; HEART FAILURE; HEART RATE; HUMAN; HYPOTENSION; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; TREATMENT OUTCOME;

BENZAZEPINES; HUMANS; SHOCK, CARDIOGENIC;

EID: 67649515625     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3231-8     Document Type: Article

References (24)

1. S. Topalian F. Ginsberg J.E. Parrillo 2008 Cardiogenic shock Crit Care Med 36 S66 74
2. K.A. Fox F.A. Anderson Jr O.H. Dabbous 2007 Intervention in acute coronary syndromes: do patients undergo intervention on the basis of their risk characteristics? The Global Registry of Acute Coronary Events (GRACE) Heart 93 177 82 (Pubitemid 46180290)
3. D. Hasdai R.A. Harrington J.S. Hochman 2000 Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation J Am Coll Cardiol 36 685 92
4. H.R. Reynolds J.S. Hochman 2008 Cardiogenic shock: current concepts and improving outcomes Circulation 117 686 97
5. F. Van de Werf J. Bax A. Betriu 2008 Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2909 45
6. T.A. Sanborn L.A. Sleeper J.G. Webb 2003 Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial J Am Coll Cardiol 42 1373 9 (Pubitemid 37267275)
7. J.S. Hochman L.A. Sleeper J.G. Webb 2006 Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction JAMA 295 2511 5 (Pubitemid 43854966)
8. T. Heer U. Zeymer C. Juenger 2006 Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice Heart 92 1484 9 (Pubitemid 44578849)
9. E.W. Chen J.G. Canto L.S. Parsons 2003 Relation between hospital intra-aortic balloon counterpulsation volume and mortality in acute myocardial infarction complicated by cardiogenic shock Circulation 108 951 7 (Pubitemid 37048224)
10. V.S. Moiseyev P. Poder N. Andrejevs 2002 Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN) Eur Heart J 23 1422 32 (Pubitemid 36285574)
11. J.T. Fuhrmann A. Schmeisser M.R. Schulze 2008 Levosimendan is superior to enoximone in refractory cardiogenic shock complicating acute myocardial infarction Crit Care Med 36 2257 66
12. J.H. Alexander H.R. Reynolds A.L. Stebbins 2007 Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial JAMA 297 1657 66 (Pubitemid 46631624)
13. Z.M. Chen H.C. Pan Y.P. Chen 2005 Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 1622 32
14. R.M. Califf J.R. Bengtson 1994 Cardiogenic shock N Engl J Med 330 1724 30 (Pubitemid 124005035)
15. H. Brown D. Difrancesco S. Noble 1979 Cardiac pacemaker oscillation and its modulation by autonomic transmitters J Exp Biol 81 175 204
16. J.D. Schipke I. Buter T. Hohlfeld 2006 Selective If channel inhibition: an alternative for treating coronary artery disease? Herz 31 55 74 (Pubitemid 43723954)
17. D. DiFrancesco P. Tortora 1991 Direct activation of cardiac pacemaker channels by intracellular cyclic AMP Nature 351 145 7 (Pubitemid 21896552)
18. J.C. Tardif I. Ford M. Tendera 2005 Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina Eur Heart J 26 2529 36 (Pubitemid 41677303)
19. W. Ruzyllo M. Tendera I. Ford 2007 Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial Drugs 67 393 405 (Pubitemid 46425552)
20. K. Fox M.A. Garcia D. Ardissino 2006 Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology Eur Heart J 27 1341 81 (Pubitemid 43998110)
21. G. Heusch 2008 Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction Br J Pharmacol 155 970 1
22. E.I. Dedkov W. Zheng L.P. Christensen 2007 Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen Am J Physiol Heart Circ Physiol 293 H590 8
23. f current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease Drugs 64 1757 65 (Pubitemid 39215187)
24. G. Heusch A. Skyschally P. Gres 2008 Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction Eur Heart J 29 2265 75